Uzbekistan National Medical Center Partners with Concord Medical to Establish Advanced Radiosurgery Center
Concord Medical has signed a 15-year Public-Private Partnership (PPP) agreement with the Ministry of Health of the Republic of Uzbekistan to jointly establish and operate a Gamma Knife Radiosurgery Center at the National Medical Center in Tashkent.
Concord Medical has signed a 15-year Public-Private Partnership (PPP) agreement with the Ministry of Health of the Republic of Uzbekistan to jointly establish and operate a Gamma Knife Radiosurgery Center at the National Medical Center in Tashkent.
The long-term partnership represents an important step in international healthcare collaboration, bringing together advanced radiation oncology expertise, clinical management, quality assurance systems, and digital healthcare solutions to strengthen cancer care services in Uzbekistan.
Unlike traditional international healthcare projects that focus primarily on equipment installation, this collaboration aims to support the development of a sustainable oncology service model through the transfer of clinical expertise, standardized treatment protocols, professional training, and hospital operational experience.
Supporting the Development of Advanced Cancer Care
As the demand for high-quality cancer treatment continues to grow worldwide, many countries are seeking long-term partnerships that combine advanced medical technologies with clinical expertise and operational excellence.
Through this collaboration, the new Gamma Knife Center will benefit from comprehensive support covering the following key areas:
- Clinical management and treatment protocols
- Radiation oncology quality assurance systems
- Professional education and workforce development
- Digital hospital management
- AI-enabled clinical support
The project reflects a shared commitment to improving access to advanced radiation therapy while strengthening local healthcare capacity.
Building Sustainable Healthcare Through International Collaboration
The partnership adopts a collaborative PPP model in which the National Medical Center provides local healthcare infrastructure and patient access, while Concord Medical contributes its experience in cancer center operation, radiation oncology management, clinical quality systems, and digital healthcare innovation.
This integrated approach is designed to support the long-term development of high-quality oncology services and improve treatment accessibility for patients across Uzbekistan.
Sustainable partnership model: The 15-year PPP agreement is designed to go beyond equipment installation, supporting the development of a self-sustaining oncology service model through long-term knowledge transfer, standardized protocols, and continuous clinical innovation.
Advancing Digital Oncology and Clinical Excellence
Beyond advanced treatment technologies, the collaboration also incorporates digital healthcare solutions to improve clinical efficiency and patient care. These integrated solutions include:
- AI-assisted clinical decision support
- Standardized quality management
- Digital hospital operation systems
- Remote multidisciplinary collaboration
- Continuous professional education
By integrating technology with clinical expertise, the partnership aims to establish a sustainable model for modern cancer care.
- AI-assisted clinical decision support: Embedding intelligent tools into clinical workflows to support safer, more accurate treatment decisions.
- Standardized quality management: Implementing unified clinical quality standards across all stages of cancer care.
- Digital hospital operation systems: Enabling data-driven management of hospital operations and clinical resources.
- Remote multidisciplinary collaboration: Connecting local teams with international experts for case review and joint decision-making.
- Continuous professional education: Building long-term workforce capability through structured training programs.
Strengthening International Medical Cooperation
The Uzbekistan project represents another important milestone in Concord Medical's international collaboration efforts and reflects the growing global recognition of China's expertise in radiation oncology and cancer center management.
The experience gained through this partnership is expected to support future collaborations in other regions while promoting knowledge exchange, professional education, and innovation in cancer treatment.
"Cancer is a global health challenge that requires collaboration across borders. Through long-term partnerships with international healthcare institutions, Concord Medical remains committed to sharing clinical expertise, advancing precision oncology, and helping more patients gain access to high-quality cancer care." — Concord Medical, International Collaboration Statement
Global recognition: The Uzbekistan partnership reflects the growing international recognition of China's expertise in radiation oncology and cancer center management, while supporting the development of advanced cancer care in Central Asia.
Looking Ahead
Cancer is a global health challenge that requires collaboration across borders.
Through long-term partnerships with international healthcare institutions, Concord Medical remains committed to sharing clinical expertise, advancing precision oncology, and helping more patients gain access to high-quality cancer care.
- Partnership type: 15-year Public-Private Partnership (PPP)
- Counterparty: Ministry of Health of the Republic of Uzbekistan
- Project location: National Medical Center, Tashkent
- Core technology: Gamma Knife Radiosurgery Center
- Capability transfer: Clinical management, quality assurance, training, digital hospital, AI-enabled clinical support
- Long-term goal: Sustainable cancer care service model for patients across Uzbekistan
About Concord Medical: Concord Medical is a leading cancer care provider specializing in advanced oncology treatment, precision radiotherapy, multidisciplinary cancer management, and international healthcare collaboration. Through its network of cancer centers and partnerships with leading institutions worldwide, Concord Medical continues to bring advanced cancer care technologies and clinical expertise to more patients across regions.